The use of human induced pluripotent stem cells (hiPSC) for modeling blood disorders

Recent advances in cellular reprogramming and stem cell biology have opened up unique opportunities in regenerative medicine, gene therapy and disease modeling. In this article, we will review these issues with particular reference to the impact of human induced pluripotent cell (hiPSC) technology in the modeling of human blood disorders.